Skip to main content
Premium Trial:

Request an Annual Quote

Appistry, PGDx Sign Deal for Cancer Panel

NEW YORK (GenomeWeb) – Appistry said today that it has signed a deal to include Personal Genome Diagnostics' CancerSelect panel in the recently released Appistry CloudDx genomics testing service.

Appistry launched the new service, which makes laboratory-developed tests from diagnostic test providers available to physicians across the US via the cloud, at the American Society of Clinical Oncology annual meeting this week in Chicago. PGDx, which offers cancer genome analyses to oncology researchers, drug developers, clinicians, and patients out of its CLIA lab, is one of the first organizations to offer its services through Appistry's new portal.

According to Appistry, its CloudDx service provides a single web dashboard for ordering and tracking the progress of tests while orchestrating a data flow between test providers and requesting physicians and hospitals. It added that the service ensures that data and physical samples are transferred and securely managed in accordance with HIPAA and CLIA guidelines.

"Making CancerSelect available through Appistry CloudDx will extend our reach, enabling our panel to be utilized more broadly by community physicians looking to provide the best diagnostic and treatment options to their patients," Antony Newton, chief commercial officer for Baltimore-based PGDx.

CancerSelect is a targeted cancer gene panel for the detection of genetic alterations in 120 well-characterized cancer genes, which are considered of clinical and biologic importance. The firm screens the genes using next-generation sequencing at "extremely high coverage to identify point mutations, copy number alterations, and translocations," according to PGDx's website.

Further terms of the agreement between Appistry and PGDx were not disclosed.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.